MARLEE PEASE: Open Payments
NPI 1114691136 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 54 payments from 10 companies in 2025. Trend: 2023 $700 · 2024 $1,124 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $397 |
| Phathom Pharmaceuticals, Inc. | 5 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| PFIZER INC. | 5 | $77 |
| Gilead Sciences, Inc. | 4 | $75 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $32 |
| QOL Medical, LLC | 1 | $28 |
| Braintree Laboratories, Inc. | 1 | $15 |
Products named: RINVOQ, VOQUEZNA, ENTYVIO, SKYRIZI, LINZESS, REZDIFFRA, VELSIPITY, ZENPEP.
Industry payments across FL — which companies pay providers there.
